Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWise Group Regulatory News (WISE)

Share Price Information for Wise Group (WISE)

Share Price is delayed by 15 minutes
Get Live Data
826.00    0.00 (0.00%)
Bid:
770.00
Ask:
0.00
Spread: 56.00 (7.273%)
Market Cap: £8.26b
WISE Live PriceLast checked at - London Stock Exchange

Intraday Wise Group Share Chart

Establishment of Euro Medium Term Note Programme

13 Nov 2025 09:14

RNS Number : 4266H
Wise PLC
13 November 2025
 

Wise Financing plc - LEI: 6488E9H7Z3K04JNN7302Wise plc - LEI: 213800LD9XCHIC1C4V71

 

THIS ANNOUNCEMENT IS NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OR IN ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAW

 

 

13 November 2025

 

WISE FINANCING PLC

 

ESTABLISHMENT OF EURO MEDIUM TERM NOTE PROGRAMME AND PUBLICATION OF ADMISSION PARTICULARS

 

 

Wise Financing plc, a wholly-owned finance subsidiary of Wise Financial Holdings Limited (a wholly-owned subsidiary of Wise plc), today announces the establishment of its Euro Medium Term Note Programme (the "Programme").

 

As part of the Programme establishment, the following admission particulars (the "Admission Particulars") have been submitted to and approved by the International Securities Market of the London Stock Exchange:

 

Admission Particulars dated 13 November 2025 relating to the Euro Medium Term Note Programme of Wise Financing plc, as Issuer, which is unconditionally and irrevocably guaranteed by Wise plc, as Parent Guarantor, and certain of its subsidiaries.

 

A copy of the Admission Particulars can be viewed on Wise plc's website at https://wise.com/owners/debt-issuance.

 

This website is not provided for, or directed at, U.S. persons or persons in the United States. If you are a U.S. person or are viewing this page from the United States, you should exit this section of the website.

 

Enquiries

Martin Adams - Owner Relationsowners@wise.com

Sana Rahman - Communicationspress@wise.com

Brunswick GroupCharles Pretzlik / Emily Murphywise@brunswickgroup.com +44 (0) 20 7404 5959

 

About Wise

 

Wise is a global technology company, building the best way to move and manage the world's money.With Wise Account and Wise Business, people and businesses can hold 40 currencies, move money between countries and spend money abroad. Large companies and banks use Wise technology too; an entirely new network for the world's money. Launched in 2011, Wise is one of the world's fastest growing, profitable tech companies.

In fiscal year 2025, Wise supported around 15.6 million people and businesses, processing over $197 billion in cross-border transactions and saving customers around $2.7 billion.

 

DISCLAIMER - INTENDED ADDRESSES

Please note that the information contained in the Admission Particulars may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Admission Particulars) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Admission Particulars is not addressed. Prior to relying on the information contained in the Admission Particulars you must ascertain from the Admission Particulars whether or not you are part of the intended addressees of the information contained therein.

The Admission Particulars do not constitute an offer of securities for sale in the United States. The notes described herein and in the Admission Particulars have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or under any relevant securities laws of any state of the United States of America, and may not be offered or sold to U.S. persons or to persons within the United States of America (as such terms are defined in Regulation S under the Securities Act) , except pursuant to an exemption from the Securities Act. For a further description of certain restrictions on offers and sales of the notes and on distribution of the Admission Particulars, see the "Subscription and Sale" section in the Admission Particulars.

Your right to access this service is conditional upon complying with the above requirement.

No offer or invitation to acquire any securities is being made pursuant to this announcement.

END

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGCBDBDBBDGUX
Date   Source Headline
18th Jul 20231:59 pmRNSDirector/PDMR Shareholding
18th Jul 20237:00 amRNSWise Plc Q1FY24 Trading Update
4th Jul 20233:22 pmRNSAnnual Financial Report
3rd Jul 20237:00 amRNSTotal Voting Rights
28th Jun 20234:00 pmRNSDirector/PDMR Shareholding
27th Jun 20237:00 amRNSWise plc Preliminary Results FY end 31 March 2023
15th Jun 20237:00 amRNSDirector/PDMR Shareholding
2nd Jun 20239:47 amRNSTotal Voting Rights
22nd May 20237:00 amRNSManagement Update
15th May 202312:31 pmRNSDirector/PDMR Shareholding
10th May 20239:30 amRNSManagement update
2nd May 20233:24 pmRNSDirector/PDMR Shareholding
2nd May 20237:00 amRNSTotal Voting Rights
25th Apr 20237:00 amRNSDirector/PDMR Shareholding
20th Apr 20237:00 amRNSDirector/PDMR Shareholding
19th Apr 20237:00 amRNSBoard Appointments
18th Apr 20237:00 amRNSWise Plc Q4 FY23 Trading Update
3rd Apr 202311:26 amRNSDirector/PDMR Shareholding
31st Mar 202312:47 pmRNSTotal Voting Rights
21st Mar 202311:24 amRNSTotal Voting Rights (Replacement)
21st Mar 202311:11 amRNSTotal Voting Rights (Replacement)
21st Mar 202310:40 amRNSTotal Voting Rights (Replacement)
24th Feb 20239:55 amRNSHolding(s) in Company
24th Feb 20237:00 amRNSHolding(s) in Company
23rd Feb 20232:43 pmRNSTotal Voting Rights
10th Feb 20232:22 pmRNSDirector/PDMR Shareholding
9th Feb 20237:00 amRNSAdditional Listing
6th Feb 202310:53 amRNSDirector/PDMR Shareholding
1st Feb 202311:13 amRNSTotal Voting Rights
18th Jan 20234:17 pmRNSDirector/PDMR Shareholding
17th Jan 20237:00 amRNSWise Plc Q3 FY23 Trading Update
3rd Jan 20237:00 amRNSTotal Voting Rights
20th Dec 20224:08 pmRNSGrant of Awards to CFO
8th Dec 20225:45 pmRNSHolding(s) in Company
5th Dec 202210:09 amRNSHolding(s) in Company
2nd Dec 20229:48 amRNSDirector/PDMR Shareholding
30th Nov 202212:10 pmRNSTotal Voting Rights
29th Nov 20227:00 amRNSWise Plc HY FY23 Interim Results
4th Nov 20222:16 pmRNSDirector/PDMR Shareholding
31st Oct 202210:31 amRNSTotal Voting Rights
21st Oct 202210:19 amRNSDirector/PDMR Shareholding
18th Oct 20227:00 amRNSStrong momentum in Q2, supports outlook for year
5th Oct 202212:06 pmRNSAdditional Listing
5th Oct 20229:00 amRNSAdditional Listing
29th Sep 20222:30 pmRNSGrowth momentum continues; guidance upgraded
23rd Sep 202212:29 pmRNSNotice of Results
22nd Sep 202210:29 amRNSHolding(s) in Company
22nd Sep 202210:18 amRNSAllotment of OwnWise Shares
13th Sep 202210:21 amRNSHolding(s) in Company
12th Sep 20223:39 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.